Pharmaceuticals Business Investment Opportunity in Hyderabad, India
Contract research & manufacturing of fine chemicals, intermediates and bulk drugs for Lupin and Centaur Pharma.
This transaction has concluded.
| Established | 5-10 year(s) |
| Employees | 5 - 10 |
| Legal Entity | General Partnership |
| Reported Sales | USD 200 thousand |
| Run Rate Sales | USD 140 thousand |
| EBITDA Margin | 10 - 20 % |
| Industries | Pharmaceuticals |
| Locations | Hyderabad |
| Local Time | 7:17 AM Asia / Kolkata |
| Listed By | Business Owner / Director |
| Status | Moderately Active |
Partial Stake Sale
USD
60 thousand
for
25.0%
stake
(Native Currency: INR 5,000,000)
Reason: Business expansion.
Includes physical assets worth
USD
30 thousand
Documents
VAT Certificate
(232.3 KB)
Excise Registartion Certificate
(251.6 KB)
Import Export License
(459.3 KB)
Firm Registration Certificate
(1.0 MB)
Business Overview
- Approved vendor for Lupin and Centaur Pharma for 4-nitroimidazole.
- We develop technologies for fine chemicals, intermediates and bulk drugs for scale up and commercialization.
- Our clients are Lupin, Naveen Fluorines, Krebs, Inogent, Vivimed etc.
- Founder has 24+ years of experience.
Products & Services Overview
Products: Intermediates of Brivaracetam, Pregabalin, Sitagliptin, Rosuvastatin, Methoxypropane,
Services: Technology Development and Transfer, Analytical Services in GC, HPLC, Marketing Support Etc.
Facilities Overview
1800 sft built up area, 2500 sft total area on lease for Rs. 21,000 / - per month.
Capitalization Overview
Not Disclosed
Recent Activity
-
Earlier than 15 daysCEO, Pharmaceuticals, Hyderabad, Individual Investor / Buyer connected with the Business
-
Earlier than 15 daysIndividual, Consultancy, Hyderabad, Individual Investor / Buyer connected with the Business
-
Earlier than 15 daysPharma Analyst, Pharma, Auckland, Individual Investor / Buyer connected with the Business
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
